1. Home
  2. AQST vs FRA Comparison

AQST vs FRA Comparison

Compare AQST & FRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AQST
  • FRA
  • Stock Information
  • Founded
  • AQST 2004
  • FRA 2003
  • Country
  • AQST United States
  • FRA United States
  • Employees
  • AQST N/A
  • FRA N/A
  • Industry
  • AQST Biotechnology: Pharmaceutical Preparations
  • FRA Investment Bankers/Brokers/Service
  • Sector
  • AQST Health Care
  • FRA Finance
  • Exchange
  • AQST Nasdaq
  • FRA Nasdaq
  • Market Cap
  • AQST 390.4M
  • FRA 449.1M
  • IPO Year
  • AQST 2018
  • FRA N/A
  • Fundamental
  • Price
  • AQST $3.96
  • FRA $13.21
  • Analyst Decision
  • AQST Strong Buy
  • FRA
  • Analyst Count
  • AQST 7
  • FRA 0
  • Target Price
  • AQST $11.29
  • FRA N/A
  • AVG Volume (30 Days)
  • AQST 1.1M
  • FRA 165.4K
  • Earning Date
  • AQST 08-11-2025
  • FRA 01-01-0001
  • Dividend Yield
  • AQST N/A
  • FRA 11.06%
  • EPS Growth
  • AQST N/A
  • FRA N/A
  • EPS
  • AQST N/A
  • FRA N/A
  • Revenue
  • AQST $54,228,000.00
  • FRA N/A
  • Revenue This Year
  • AQST N/A
  • FRA N/A
  • Revenue Next Year
  • AQST $51.62
  • FRA N/A
  • P/E Ratio
  • AQST N/A
  • FRA N/A
  • Revenue Growth
  • AQST 5.29
  • FRA N/A
  • 52 Week Low
  • AQST $2.12
  • FRA $11.33
  • 52 Week High
  • AQST $5.80
  • FRA $13.10
  • Technical
  • Relative Strength Index (RSI)
  • AQST 50.64
  • FRA 57.05
  • Support Level
  • AQST $3.73
  • FRA $13.14
  • Resistance Level
  • AQST $4.10
  • FRA $13.25
  • Average True Range (ATR)
  • AQST 0.22
  • FRA 0.07
  • MACD
  • AQST -0.07
  • FRA -0.02
  • Stochastic Oscillator
  • AQST 17.42
  • FRA 76.67

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

About FRA Blackrock Floating Rate Income Strategies Fund Inc

Blackrock Floating Rate Inc Stra Fd Inc is a United States-based diversified closed-ended management investment company. The Fund's investment objective is to provide shareholders with high current income and preservation of capital with investment in a diversified, leveraged portfolio consisting of floating-rate debt securities and instruments.

Share on Social Networks: